Private Equity Firm Healthcare

Sheridan Capital Partners

Chicago, Illinois, United States

Healthcare private equity firm focused on lower middle market buyouts and growth equity in the U.S. and Canada. Sheridan partners with providers and provider services, healthcare IT and outsourced services, and consumer health and medical products to accelerate growth and build enduring value.

Focus Areas
Healthcare IT, Provider Services, Healthcare Outsourced Services
Website
sheridancp.com

Tracked deals

30

30 tracked deals across 2019-2026.

Recent pace

5

5 tracked deals announced in the last 12 months.

Deal mix

Addon

16 addon · 11 growth capital · 2 buyout

Sheridan Capital Partners Acquisition Volume by Year

Last 8 years

Acquisition volume by year Annual acquisition counts for the last 8 years for Sheridan Capital Partners. 2 2019 3 2020 5 2021 6 2022 4 2023 5 2024 2 2025 ~5 est. 3 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

Showing the 12 most recent of 30 tracked deals for Sheridan Capital Partners.

  • Buyer
    Sheridan Capital Partners
    Target
    Tres Health, Inc., Tres Health
    Seller
    Michael Feeney, Ari Rostowsky, David Morris

    Sheridan Capital Partners completed an investment in Tres Health, a Boca Raton, Florida-based alternative health insurance and technology provider. The firm is backing Tres’s employer-facing platform (including its TresTech digital suite) focused on small and medium-sized businesses’ options to manage rising healthcare costs.

  • Buyer
    Sheridan Capital Partners
    Target
    ICANotes
    Industry
    Software
    Type
    Buyout

    Sheridan Capital Partners completed an investment in ICANotes, a purpose-built electronic health record (EHR) and practice management platform serving behavioral health providers. Financial terms were not disclosed; Sheridan said it will support ICANotes' product development and nationwide expansion to scale the company's behavioral-health-focused EHR and practice management capabilities.

  • Buyer
    Currier Plastics, Sheridan Capital Partners
    Target
    Springboard Manufacturing, MOS Plastics
    Seller
    HC Private Investments
    Industry
    Manufacturing
    Type
    Addon

    Currier Plastics, a Sheridan Capital Partners portfolio company, has completed the acquisitions of Springboard Manufacturing and MOS Plastics. The add-on deals expand Currier's West Coast footprint, add significant Class 7/8 cleanroom capacity, and deepen capabilities serving pharmaceutical, medical device and diagnostics customers.

  • Buyer
    Sheridan Capital Partners
    Target
    Currier Plastics
    Industry
    Manufacturing
    Type
    Buyout

    Sheridan Capital Partners has completed an investment in Currier Plastics, a precision custom plastics manufacturer serving healthcare and life sciences, and appointed Andrew McLean as Currier's new CEO. The private equity partnership will support Currier’s organic growth initiatives and strategic M&A to expand its medical contract manufacturing capabilities.

  • Buyer
    Sheridan Capital Partners
    Target
    National Care Systems

    Sheridan Capital Partners completed an investment in National Care Systems (NCS), a Brooklyn-based provider of revenue cycle management and payroll software serving skilled nursing and assisted living facilities across the United States. The investment will support NCS’s expansion of partnerships with post-acute facilities while founder and CEO David Klein remains in place; financial terms were not disclosed.

  • Buyer
    Empower Physical Therapy, Sheridan Capital Partners, SV Health Investors
    Target
    Doctors of Physical Therapy
    Type
    Addon

    Empower Physical Therapy has combined with Doctors of Physical Therapy (DPT) to create a larger outpatient and industrial physical therapy network. The deal, which closed in December 2024, brings DPT's more than 100 locations and 300+ practitioners into Empower's platform (backed by Sheridan Capital Partners) and will be supported going forward by Sheridan Capital Partners and SV Health Investors; Aaron Kraai (founder of DPT) will serve as CEO of the combined company.

  • Buyer
    Tarrytown Expocare Pharmacy, Sheridan Capital Partners
    Target
    Greater Boston Long Term Care Pharmacy
    Seller
    Mike Wessenberg (Founder / Former CEO)
    Type
    Addon

    Tarrytown Expocare Pharmacy, a national long-term care pharmacy focused on IDD and behavioral health, has acquired Greater Boston Long Term Care Pharmacy to establish a Massachusetts presence. The deal, supported by Sheridan Capital Partners and advised on the sell-side by M&A Healthcare Advisors, adds a regional location to Tarrytown's platform and aims to expand services to group homes and assisted living communities across the Commonwealth.

  • Buyer
    DAS Health Ventures, LLC (DAS Health)
    Target
    North American Digital Health division of an established Canadian digital transformation provider (unnamed)
    Location
    Canada
    Type
    Addon

    DAS Health Ventures (a Sheridan Capital Partners portfolio company) acquired the North American Digital Health division of an established Canadian digital transformation provider, giving DAS Health a footprint in Canada and expanding its senior care-focused health IT capabilities. The division adds managed IT, cybersecurity, cloud hosting, integrations, and revenue cycle management services to DAS Health's offerings as an add-on to its existing platform.

  • Buyer
    Ascend Plastic Surgery Partners, Sheridan Capital Partners
    Target
    Ponte Vedra Plastic Surgery
    Seller
    Founding partners of Ponte Vedra Plastic Surgery (Dr. Cayce Rumsey, Dr. Robert Burk, Dr. Erez Sternberg, Dr. Hollie Hickman, and CEO Dennis Oistacher)
    Type
    Addon

    Ascend Plastic Surgery Partners, backed by Sheridan Capital Partners, has acquired Ponte Vedra Plastic Surgery, expanding Ascend's footprint into Florida by adding six surgeons and six locations. The PVPS founding partners and leadership will remain involved as the practice integrates into Ascend's platform to continue delivering aesthetic medicine services.

  • Buyer
    Sheridan Capital Partners, Neuberger Berman, Aquarian Investments
    Target
    Oral Surgery Partners

    Oral Surgery Partners, a Sheridan Capital Partners-backed oral surgery practice management platform headquartered in Missouri, closed a $400+ million credit expansion in partnership with funds managed by Neuberger Berman and Aquarian Investments to support infrastructure, hiring, and add-on acquisitions. The capital will enable OSP to continue nationwide roll-up activity, invest in systems and personnel, and recruit additional surgeon partners.

  • Buyer
    Sheridan Capital Partners, Ascend surgeons and management
    Target
    Five plastic surgery practices (combined into Ascend Plastic Surgery Partners), Two standalone MedSpas (combined into Ascend Plastic Surgery Partners)

    Sheridan Capital Partners has formed Ascend Plastic Surgery Partners, a physician practice management MSO focused on plastic surgery and aesthetics, by investing alongside surgeons and management. Ascend, headquartered in Atlanta, Georgia, combines five plastic surgery practices and two standalone MedSpas and will provide services across Alabama, New Mexico, South Carolina, and Utah; financial terms were not disclosed.

  • Buyer
    Sheridan Capital Partners
    Target
    FirstEnroll

    Sheridan Capital Partners, a Chicago-based healthcare private equity firm, has made a minority growth investment in FirstEnroll, a Tinton Falls, New Jersey-based health insurance billing and enrollment third-party administrator. FirstEnroll's founder and CEO retained meaningful ownership and will remain active; the partnership will fund organic initiatives and support a targeted M&A strategy to scale the business.

Related Acquisition Pages

Selling a company? Get in front of buyers like Sheridan Capital Partners

Turn tracked acquisition activity into an outreach-ready buyer list.